Clinical Trial Update: Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating the safety and efficacy of Kaletra in antiretroviral therapy-experienced HIV patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED